Study of p53 and its Isoform Δp53 in Breast Cancer
Author Information
Author(s): Baumbusch Lars O, Myhre Simen, Langerød Anita, Bergamaschi Anna, Geisler Stephanie B, Lønning Per E, Deppert Wolfgang, Dornreiter Irene, Børresen-Dale Anne-Lise
Primary Institution: Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway
Hypothesis
Does the expression of p53 and its isoform Δp53 correlate with mutation status and clinical parameters in breast cancer?
Conclusion
The study found that the expression of p53 and Δp53 is correlated in breast tumors, with different mutation types affecting their levels.
Supporting Evidence
- Patients with mutated full-length p53 and wild-type Δp53 showed a higher frequency of distant metastasis.
- Expression levels of p53 and Δp53 were significantly correlated in both wild-type and mutated tumors.
- Different mutation types resulted in varying mRNA expression levels for both isoforms.
Takeaway
This study looked at how two forms of a gene called p53 behave in breast cancer and found that they often work together, but mutations can change how they act.
Methodology
The study analyzed mRNA expression of p53 and Δp53 in tumor samples using quantitative real-time PCR and correlated the findings with clinical data.
Potential Biases
Potential biases may arise from the selection of tumor samples and the methods used for mutation analysis.
Limitations
The study had a small sample size and may not represent all breast cancer cases.
Participant Demographics
The study included 88 breast cancer patients with advanced disease.
Statistical Information
P-Value
p<0.00002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website